INTERVIEW WITH ANDREW BASKIN, MD
AND MOHAMED DIAB, MD

Andrew-Baskin-headshot-1Andrew Baskin, MD, is Aetna’s Vice President, National Medical Director for Quality and Clinical Policy and served as the Interim Chief Medical Officer (in 2014). He works on initiatives to measure and improve quality of care, the provision of evidence based care, quality measurement implementation and public reporting, health plan accreditation, and the establishment of performance based networks. Additionally, Andy partners with others to help establish programs which create incentives for more effective and efficient care, influence and assure compliance with healthcare reform regulations, develop products to improve affordability and quality of care, and promote payment reform.

mohamed-diab-headshot.png-300x300

Mohamed Diab, MD, Vice President of Provider Transformation leads population health management at Aetna. His focus is on providers as they transform their care delivery to achieve the “Triple Aim” by improving quality of care and reducing unnecessary cost. Mohamed has more than 25 years of experience as a provider as well as an executive in the payer and consulting industries. He has a background in medical management, pharmacy benefit management, clinical informatics and cost management programs.


Key Takeaways

  • There is a limit to what each sector of the health ecosystem can do on its own. Collaboration is a good business strategy that can lead to greater impact and better outcomes.
  • Choosing the right partner for collaboration is the key to success. The partners need to align on a common goal, shared incentives, and shared accountability.
  • For collaboration to truly work, each organization needs to communicate the combined impact to ensure its success.

TLD Group: What role does Aetna play in improving the health of the populations it serves?

Baskin: As an organization, Aetna has taken a more expansive view of our role, from that of a health insurer, which is the more traditional role of paying claims or managing actuarial risk, to that of a health plan. This broader view encompasses more services such as care management, stronger provider collaborations, and advanced analytics to ultimately being a health company that improves the well-being of our members. We are beginning to focus more on the social issues that influence health. For example, instead of simply insisting that a patient adhere to his or her medication, we may ask why they are having difficulty doing so. Perhaps they can’t afford their medications or don’t have transportation to the pharmacy. By uncovering the underlying issues that may interfere with health, we can connect with our members to provide resources to address the broader issues so they have a better opportunity to improve their health.

TLD Group: How would you describe Aetna’s health ecosystem?

Baskin: The way I see it, all of the players in the health ecosystem share the goal of improving health outcomes and making health more affordable. If all players can learn to work in concert, we can have a greater impact. There is a limit to what each of us can do on our own. Working collaboratively can lead to better outcomes. It’s a tough thing to do, because the health ecosystem players are accustomed to working in their own separate silos. I’m proud to say that, in recent years Aetna has seen an intensification of our collaboration with healthcare providers, which would have been unheard of in the industry when I first started at Aetna 19 years ago. We know that collaborating with healthcare providers has greater potential to impact the health of our members through improved efficiency and quality of care.

TLD Group: Can you provide an example of a collaborative effort between Aetna and another player in the health ecosystem?

Baskin: Collaboration is a good business strategy. Aetna is a national insurer, but we don’t have membership equally distributed throughout the country. We don’t necessarily have the same penetration in the insurance market in every state. For example, we had a lot of business in the D.C. area, but had less membership in northern Virginia. Our growth in that area was slow because we were competing against a very large local insurance company who had the lion’s share of the market. That local insurer is a well-known, well-established, dominant payer in that area. One strategy would have been to lower our prices to try to attract business away from the top player, but that has been a failing strategy many times over the years. The better strategy was to find a local partner. Inova Health System was a trusted provider in the community with a large market share, and was interested in moving into the insurance business. However, there’s a lot to becoming a health insurer, and they knew they didn’t have the expertise to do it on their own. To that end, they sought a joint venture (JV) partner, Aetna was a great fit, and Innovation Health was born. Our respective organizations are 50% owners, so it is a true equal partnership whereby both organizations share in the profit or risk of the joint venture. That’s a very convincing collaborative strategy. To date, we have five joint ventures similar to this example.

TLD Group: What is your approach to developing joint venture partnerships?

Diab: We rarely jump right into a JV relationship, because it is the utmost form of partnership. We often start working with the health system in an ACO-attribution model. Many health systems these days want to do an ACO, but we are very selective about who we chose to partner with to ensure success. To select potential partners, my team conducts a comprehensive assessment of the health system. We spend several days learning about their capabilities in terms of a clinically-integrated network, control over their physician network, population health technology, care management infrastructure, etc. We have a playbook of national best-practices that we developed by working with health systems around the country. Through our assessment, we can identify where a potential partner stands in relation to the national best-practices to determine their potential to succeed as a population health organization, to grow membership, become more efficient, and enhance their services and care delivery. If we deem that the system has low potential, we will walk away. If we believe that they have the right culture, mindset, and mission, we will further the dialogue toward a JV.

Baskin: There are circumstances where we may decide that a JV would make more sense than an ACO relationship. In the case of Innovation Health, the joint partnership was mutually beneficial for both of our organizations’ strategic direction. The collaboration was both a growth strategy and an opportunity to impact the health of a greater number of people. For Aetna, this partnership gave us a competitive advantage in the northern Virginia market. For Inova Health, partnering with Aetna provided access to more clinical information, stronger analytics, and more robust care management models. By combining our respective organizations’ unique capabilities, we had a greater capacity to improve the quality of care as well as the patient experience and outcomes. An important point to note is that each joint venture is unique. If you’ve seen one JV, you’ve seen one JV. Each JV is a unique combination of the capabilities of the respective partners, leading to a very different JV than the one before it. There are certainly some common themes, but the actual implementation is unique to each JV and its environment.

TLD Group: Can you share with us a success story on aligning on a common purpose between sectors?

Diab: Banner Health started with us as an ACO relationship that resulted in positive outcomes for our members, Aetna, and Banner Health. Banner Health was able to meet quality criteria, the targets set for the total medical cost, and the ability to manage the risk upside and downside. With the ACO product, we were able to reduce avoidable admission by 24% and avoidable ED visits by 12%, take waste out of the system, and enhance the quality of the results and member satisfaction. Because we saw signs of early success, we entered into discussions to move toward a JV partnership. We ultimately went to market with a new insurance company called Banner-Aetna. This is a true partnership in which we share the total premium dollars 50/50.

TLD Group: How do you align on capabilities when partnering with another sector?

Diab: Our process is to look at the capabilities of each organization and collectively decide which services will be provided by each organization. When you bring two large organizations together around a common mission, it takes a lot of time to truly grasp the concept and understand what each organization is going to bring to the table. It’s an arduous process where every area of the organization is involved in the discussion – finance, compliance, regulatory, legal, pharmacy, medical management, etc. It can take at least 1 ½ years of detailed negotiations and capability comparisons to determine what the infrastructure will look like. As an illustrative example, we discovered that Banner had a robust specialty pharmacy capability. As a major cost driver, we decided it made more sense to delegate specialty pharmacy to Banner because it’s part of the clinically integrated network, and Aetna would complement it with wrap-around services around local capabilities.

TLD Group: In a broad sense, how do you gain buy-in from internal stakeholders for collaborative joint venture initiatives?

Baskin: When it comes to getting internal stakeholders on-board with JVs, senior leadership from both organizations has definitely had to put forth a culture change campaign. For the last several years, we have had constant and consistent messaging from the top-down about why collaboration is necessary to be successful in the future. Top leaders need to exemplify the culture they are trying to put forth by engaging front-line workers, letting them know they are meaningful contributors and communicating their impact on the success of the collaborative. This is particularly important with physicians in both organizations, who often are accustomed to working independently, and not necessarily as part of a larger system and collaborative relationship.

TLD Group: What is required to make collaboration between two parties successful?

Baskin: The people leading these efforts have to enter the conversation with an openness to try something new, and willingness to utilize the experience of the people sitting around the table. If you value diversity of viewpoints – which at Aetna, we value highly – the conversations come naturally in these new situations. The ability to accept diverse backgrounds, experiences, knowledge, and perspectives is pivotal. You have to go into these conversations with the recognition that the people you’re working with bring as much to the table as you do, and listen to their unique input.

 

View our other HELM Q&A Interviews:

poonam-alaigh-254x300-2

Poonam Alaigh, MD, Remedy Partners, Inc.

Read More

Poonam Alaigh, MD, MSHCPM, FACP, is the Executive Vice President of Commercial Business at Remedy Partners, Inc., an organization focused on mobilizing payment reform by creating software and services that enable payers, employers, and at-risk providers to organize and finance healthcare delivery around a patient’s episode of care. Dr. Alaigh was previously the Acting Under Secretary for the U.S. Department of Veterans Affairs (VA), where she directed a healthcare system with an annual budget of over $70 billion and over 300K employees, overseeing the delivery of care to more than 9 million enrolled veterans.

Read More

Andrew-Baskin-headshot-1

Andrew Baskin, MD, and Mohamed Diab, MD, Aetna

Read More

Andrew-Baskin-headshotAndrew Baskin, MD, is Aetna’s Vice President, National MedicalDirector for Quality and Clinical Policy and served as the Interim Chief Medical Officer (in 2014). He works on initiatives to measure and improve quality of care, the provision of evidence based care, quality measurement implementation and public reporting, health plan accreditation, and the establishment of performance based networks. Additionally, Andy partners with others to help establish programs which create incentives for more effective and efficient care, influence and assure compliance with healthcare reform regulations, develop products to improve affordability and quality of care, and promote payment reform.

Mohamed Diab, MD, Vice President of Provider Transformation leads population health management at Aetna. His focus is on providers as they transform their care delivery to achieve the “Triple Aim” by improving quality of care and reducing unnecessary cost. Mohamed has more than 25 years of experience as a provider as well as an executive in the payer and consulting industries. He has a background in medical management, pharmacy benefit management, clinical informatics and cost management programs.


Read More

Tanisha_Carino_17_Photo-002-280x300-1

Tanisha Carino, Ph.D.,
GSK

Read More

Tanisha Carino, Ph.D., serves as Vice President, U.S. public policy at GSK, which is committed to helping people do more, feel better and live longer. In her role, Dr. Carino promotes public policies in the best interest of patients and the public’s health. Prior to GSK, Tanisha served as Executive VP at Avalere Health, a strategic health care advisory company, where she oversaw advisory and research services to the nation’s leading life sciences companies. Dr. Carino brings over 15 years of experience in consulting, management, health policy and strategy development across government, industry and academia. She is a recognized thought leader in the evolving U.S. regulatory environment, market access and commercial trends, as well as health technology and evidence-based medicine.


Read More

Carmouche

David Carmouche, MD, Ochsner Health System & Ochsner Health Network

Read More

David Carmouche, MD, is Senior Vice President of Ochsner Health System and President of Ochsner Health Network in Louisiana. In his current role, David is responsible for clinical integration, population health strategies, development of a data and analytics infrastructure, care management, network administration and insurance product development. David joined Ochsner with 19 years of progressive healthcare leadership experience in medicine and operations. Before joining Ochsner, Dr. Carmouche served as the Executive Vice President of External Operations and Chief Medical Officer at Blue Cross Blue Shield of Louisiana in Baton Rouge where he successfully led important initiatives designed to organize care, improve quality, and increase affordability.

Read More

carman-ciervo-headshot-1

Carman Ciervo, DO, Jefferson Health New Jersey

Read More

Carman Ciervo, D.O., FACOFP, is the Executive Vice President and Chief Physician Executive at Jefferson Health New Jersey (JHNJ). As a member of the senior leadership team since 2010, Carman has played a key role in Jefferson Health of New Jersey’s continued growth and transformation, working directly on hospital and health system initiatives related to the employed-physician model, population health, and clinical excellence. He has also overseen the progressive growth of the Jefferson Health New Jersey (formerly Kennedy) Health Alliance, a consumer-friendly network of primary and specialty medical practices throughout southern New Jersey.

Read More

Bob-Garrett-headshot

Bob Garrett, John Lloyd, and Patrick Young, Hackensack Meridian Health

Read More

Bob-Garrett-headshotRobert C. Garrett is Co-CEO of Hackensack Meridian Health, which has four hospitals ranked among the top 10 in New Jersey according to U.S. News & World Report – including No. 1 ranked Hackensack University Medical Center - more than any other network in the state. Robert focused on aggressive expansion of the Hackensack University Network before its merger with Meridian Health. As Co-CEO, Robert concentrates on innovation and leading partnerships, including launching New Jersey’s first private medical school with Seton Hall University and a historic partnership with Memorial Sloan Kettering Cancer Center.

John K. Lloyd is Co-CEO of Hackensack Meridian Health, one of the largest, most comprehensive health networks in New Jersey, which includes 13 hospitals, 28,000 team members, more than 6,000 physicians and over 140 patient care locations across the state. John has focused much of his career on developing a full continuum of care – long before national health care reform mandated such changes. As Co-CEO, John oversees all non-acute care hospital businesses, including population health and the foundations. John’s expertise and vision have helped the network meet and exceed the challenges of health care reform.

Patrick R. Young is president of Population Health for Hackensack Meridian Health, where he leads the Population Health division and is responsible for accelerating the development of strategic priorities related to health care reform; population health management; Meridian’s Medicare Shared Savings Accountable Care Organization; Hackensack Meridian Health Partners, Hackensack Meridian Health’s clinically integrated network; health insurance partnerships; as well as overseeing Managed Care.

Read More

Matt-Guy-Photo

Matthew Guy, Accelerated Transformation Associates

Read More

Matthew Guy, a health ecosystem convener, is President and Owner of Accelerated Transformation Associates, and specializes in clinical, community, and population health transformation. Through his work with ReThink Health, he provides great insights on his work to convene groups in systemic changes to positively impact the health of the populations within Sonoma Country, CA; Bend, OR; and Albequerque, NM.

Read More

Bob-Hemker-Palomar-Health-CEO_8x10-240x300

Bob Hemker,
Palomar Health

Read More

Bob Hemker is the former (now retired) President and CEO of Palomar Health, a district health system serving the health needs of the largest health care district in the Northern San Diego region. In addition to three hospitals, namely Palomar Medical Center Escondido, Palomar Medical Center Downtown Campus, and Palomar Medical Center Poway, Palomar Health offers home health care, surgery, skilled nursing, ambulatory care, behavioral health services, wound care, community health education programs and Level II Trauma service. Bob has extensive experience managing the strategic, financial, and operational aspects of healthcare organizations, working closely with communities, physicians, and board representatives.

Read More

Roland_Lyon-headshot

Roland Lyon, Kaiser Permanente (KP) of Colorado

Read More

Roland Lyon is president of Kaiser Permanente (KP) of Colorado, where he leads the state’s largest nonprofit health plan, providing healthcare to approximately 670,000 members in Denver/Boulder, Southern Colorado, Northern Colorado, and the mountain communities of Summit and Eagle counties. Lyon joined KP in 2002, initially based in California before coming to Colorado in 2006. His roles in California included vice president of consulting and capital planning in KP’s Northern California region, and vice president of strategic planning in KP’s national program offices.

Read More

Julie Miller-Phipps

Julie Miller-Phipps, Kaiser Foundation Hospitals and Health Plan in So. CA

Read More

Julie Miller-Phipps is the President of Kaiser Foundation Hospitals and Health Plan in Southern California, where in partnership with leaders of Southern California Permanente Medical Group she directs operations for the region’s 14 hospitals and 222 medical offices. Julie previously served as President of Kaiser Foundation Health Plan of Georgia where she was responsible for the delivery of health care needs to nearly 300,000 Kaiser Permanente members who are served through a network of 26 medical offices and specialty centers, as well as four contracted hospitals.

Read More

Mills-photo-169x300

Donna Mills, Central Oregon Health Council

Read More

Donna Mills is the Executive Director of Central Oregon Health Council. The Council convenes stakeholders across the health ecosystem to create and implement programs in service to the mission of better health, better care, and better value for healthcare in the Central Oregon Region. As a seasoned healthcare professional with experience in leadership positions in healthcare, finance, and operating management, Donna has a proven track record recommending and executing business and financial solutions and initiatives, ultimately contributing to an organization’s financial results.

Read More

josh-ofman-1

Josh Ofman, MD,
Amgen

Read More

Joshua J. Ofman, MD, MSHS, is the Senior Vice President, Global Value, Access and Policy at Amgen ensuring the integration of reimbursement needs into the product development and commercialization process. In prior roles, Dr. Ofman was an academic gastroenterologist at Cedars-Sinai Health System and Senior Vice President of Zynx Health Inc., focused on evidence-based clinical information for quality improvement and reimbursement, and health economics strategy for life sciences companies. Dr. Ofman received his advanced medical training in Gastroenterology from UCLA and his Health Services Research training from the RAND/UCLA/VA program.

Read More

Barry-Ostrowsky-headshot-224x300

Barry Ostrowsky, RWJBarnabas
Health

Read More

Barry H. Ostrowsky is President and Chief Executive Officer for RWJBarnabas Health, New Jersey’s largest not-for-profit integrated health care delivery system and the largest private employer in the state. Mr. Ostrowsky joined Saint Barnabas Medical Center in 1991 as Executive Vice President and General Counsel. He served in the same role at Barnabas Health, when the System was created in 1996. He assumed the title of President and Chief Operating Officer in 2010, and became President and Chief Executive Officer in January 2012. Prior, Mr. Ostrowsky was a Senior Partner in the law firm of Brach Eichler. He received a BA from Rutgers University and a JD from the University of Tennessee School of Law.

Read More

bob-sachs-1

Bob Sachs, Ph.D.

Read More

We are thrilled to share our first in a series of interviews on Leading in Today’s Health Ecosystem. This month, we had the great pleasure of interviewing Bob Sachs, PhD, Talent Strategy Advisor, Executive Coach, and Advisory Board Chair for TLD Group, about the importance of developing leaders who have the capacity to work collaboratively across healthcare sectors to drive population health and reduce healthcare costs. Bob, formerly the VP of National Learning and Development at Kaiser Permanente and a national leader in integrated healthcare, works with organizations to enhance and integrate critical leadership talent strategies and systems, on learning strategy and governance.

Read More

Samitt_Craig_AnthemHeadshot

Craig Samitt, MD, MBA,
Anthem, Inc.

Read More

Craig Samitt, MD, MBA, is the EVP and Chief Clinical Officer at Anthem, where he is responsible for establishing, leading, and executing overall clinical vision and strategy for Anthem, the second largest health insurer in the US. In this role, Craig leads all clinical operations and policy as well as Anthem’s diversification strategy, from payer as a benefit-management company to payer as partner, enabler, and convener. An internal medicine physician by training, Craig has worked across multiple sectors within the health ecosystem including providers, payers, and policy makers. His work specializes in turnaround management, growth of physician networks, enhancing integrated delivery systems, and diversifying health plans in competitive markets.

Read More

lorie-1

Lorie Shoemaker, DHA, RN, MSN, CHI - Texas Division

Read More

Lorie Shoemaker, DHA, RN, MSN, is the SVP and Chief Nursing Officer at CHI – Texas Division, where she is responsible for the oversight of the quality of nursing care and nursing practice across the acute and post-acute care continuum. Prior to joining CHI St. Luke’s Health, Dr. Shoemaker served in a variety of leadership roles over a 29-year career at Palomar Health in California, including the System Chief Nurse Executive. In this role, Dr. Shoemaker provided oversight for nursing care across the system that included three acute care hospitals, two skilled nursing facilities, as well as ambulatory and home health agencies.

Read More

joe-wilkins-headshot

Joe Wilkins, MBA, FACHE, Atlantic Health System

Read More

Joe Wilkins, MBA, FACHE, is the Senior Vice President, Chief Transformation Officer at Atlantic Health System. As a healthcare industry executive, Mr. Wilkins has repeatedly driven significant organizational transformations. Mr. Wilkins has dedicated his career to executive management and boardroom leadership within healthcare organizations. He strives to make a difference within our communities, to advance healthcare equity, innovation and transformation, while expanding access, affordability and improving the quality of healthcare and mental health services.

Read More